Gvoke hypopen 2PK 0.5MG/0.1 ML 0.1ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1UX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,067
Award facts
- Contract value 100% obligated
- $2,066.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,066.98 to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gvoke Hypoepen 2-packs (0.5mg/0.1mL auto-injectors). The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. The contract is scheduled for completion by December 4, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a broad range of medications, medical devices, and healthcare commodities to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare programs. The company's extensive federal contract portfolio demonstrates its capability to fulfill open competition requirements across diverse therapeutic domains, ranging from specialty medications to vaccines and medical supplies. The Gvoke Hypoepen product being delivered under this order is a glucagon auto-injector used for emergency treatment of severe hypoglycemia in patients with diabetes, reflecting the company's role in supporting comprehensive military medical supply needs through the DLA's pharmaceutical procurement infrastructure.
Quick answers
Who was awarded contract SPE2DR26FG1UX?
SPE2DR26FG1UX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FG1UX worth?
The government has obligated $2,067 on SPE2DR26FG1UX.
Is contract SPE2DR26FG1UX an order under another contract?
Yes. SPE2DR26FG1UX is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1UX competed?
The extent of competition for SPE2DR26FG1UX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award